WHO Recommends MSF-Led EndTB Clinical Trial Treatments for Multidrug-Resistant Tuberculosis

WHO Recommends MSF-Led EndTB Clinical Trial Treatments for Multidrug-Resistant Tuberculosis The World Health Organization (WHO) has recently made a groundbreaking announcement by recommending three new treatment regimens for multidrug-resistant tuberculosis (MDR-TB). These regimens were developed based on the results of the EndTB clinical trial, a multi-year study led by Doctors Without Borders/Médecins Sans Frontières (MSF). […]